Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2026-01-13 @ 5:52 PM
Study NCT ID:
NCT04645602
Status:
RECRUITING
Last Update Posted:
2025-11-13
First Post:
2020-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Merck IIT: RRP Pembro and Lenvatinib
Sponsor:
Yale University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
HIC 2000035849
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None